Results 201 to 210 of about 274,722 (228)
Some of the next articles are maybe not open access.

EPITOPE STUDY RESULTS: PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF EPICUTANEOUS IMMUNOTHERAPY IN PEANUT-ALLERGIC TODDLERS

Annals of Allergy, Asthma & Immunology, 2022
A. Burks   +7 more
semanticscholar   +1 more source

The Clinical Utility of Epicutaneous Immunotherapy for Peanut Allergy

The Journal of Allergy and Clinical Immunology: In Practice, 2019
Miriam, Samstein, Punita, Ponda
openaire   +2 more sources

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein   +2 more
exaly  

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera   +2 more
exaly  

American Cancer Society Head and Neck Cancer Survivorship Care Guideline

Ca-A Cancer Journal for Clinicians, 2016
Nader Sadeghi   +2 more
exaly  

Spirituality and religion in oncology

Ca-A Cancer Journal for Clinicians, 2013
John R Peteet
exaly  

P273 What happens when epicutaneous peanut immunotherapy ends?

Annals of Allergy, Asthma & Immunology, 2016
M. Lewis   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy